Please select an option below to help us tailor your newsletter to best suit your content interests!
West Medical Oncologists, Dr. Bradley Somer and Dr. Gregory Vidal are two of the presenters for the upcoming Best of ASCO – Memphis Conference. Dr. Vidal will host two sessions: the SEEK Workshop Primer Panel and Diversity in Cancer Care, while Dr. Somer will host a session on GU Cancers. This Post ASCO Review will… Read more »
Key Risk Factors Affecting Treatment Choice in Melanoma West provider, Dr. G. Gary Tian, joins Dr. Evan J. Lipson with John Hopkins Medicine and other oncology experts to discuss critical factors influencing physicians’ decisions between monotherapy and doublet therapy for Metastatic Melanoma. The group dives into the latest treatment options for metastatic melanoma,… Read more »
In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer. Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »
Meet Judy: Esophageal Cancer Survivor Judy came to our West family after she and her husband moved from Florida to Memphis post-retirement. While in Florida, Judy was at high risk for developing esophageal cancer and received frequent screenings to ensure early detection. She was ultimately diagnosed with Stage IV esophageal cancer and would have… Read more »
Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »
CALLING ALL REGIONAL PROVIDERS From now through November, our West family is partnering with Total Health Conferencing to host “Cancer Updates: A Dinner Series for Community Care Teams.” These dinners will consist of educational discussions designed for oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of various cancers. Each tumor-focused program is comprised… Read more »
Our West family is 1 of only 2 sites across the country to host this clinical trial for patients with recurrent or unresectable skin cancers. “After 12 weeks post-treatment, complete response was observed in all 10 patients (100%)! CT scans at 24 weeks post-treatment showed NO EVIDENCE OF RECURRENT DISEASE in any of the patients.”… Read more »
Geriatric Oncology is a strong field of interest for our Radiation Oncologist and Co-Director of Clinical Research, Dr. Noam VanderWalde. In this podcast, he discusses the importance of personalization for older cancer patients alongside Dr Akila Viswanathan (Johns Hopkins Medicine) and Dr Ben Movsas (Henry Ford Cancer Institute – Detroit). Click here to listen!
Meet Michelle! Her journey with our West Cancer Center family has been empowering, emotional, and inspiring. To know her is to absolutely adore her. Throughout her cancer journey, Michelle takes motivation from her own hardships to pour love and advice into others. In this video, Michelle shares details of her battle with t-cell lymphoma, how… Read more »
Through research and partnerships across the oncology community, we are committed to closing the gap in existing disparities in cancer care. A new study in partnership with Dr. Gregory Vidal and our West family, OneOncology, Genentech, and Flatiron Health examined elements of inequity in next generation sequencing (NGS) for patients with advanced non-small cell lung… Read more »